4 research outputs found
Systems Biology and Systems Pharmacology of Thrombosis
Thrombus formation in flowing blood is a complex time- and space-dependent process of
cell adhesion and fibrin gel formation controlled by huge intricate networks of
biochemical reactions. This combination of complex biochemistry, non-Newtonian
hydrodynamics, and transport processes makes thrombosis difficult to understand. That is
why numerous attempts to use mathematical modeling for this purpose were undertaken during
the last decade. In particular, recent years witnessed something of a transition from the
“systems biology” to the “systems pharmacology/systems medicine” stage: computational
modeling is being increasingly applied to practical problems such as drug development,
investigation of particular events underlying disease, analysis of the mechanism(s) of
drug’s action, determining an optimal dosing protocols, etc. Here we review recent
advances and challenges in our understanding of thrombus formation
ATP-dependent K+ channels in renal ischemia reperfusion injury
ATP-dependent K+ channels (K-ATP) account for most of the recycling of K+ which enters the proximal tubules cell via Na, K-ATPase. In the mitochondrial membrane, opening of these channels preserves mitochondrial viability and matrix volume during ischemia. We examined KATP channel modulation in renal ischemia-reperfusion injury (IRI), using an isolated perfused rat kidney (IPRK) model, in control, IRI, IRI + 200 muM diazoxide (a K-ATP opener), IRI + 10 muM glibenclamide (a K-ATP blocker) and IRI + 200 muM diazoxide + 10 muM glibenclamide groups. IRI was induced by 2 periods of warm ischemia, followed by 45 min of reperfusion. IRI significantly decreased glomerular filtration rate (GFR) and increased fractional excretion of sodium (FENa) (p < 0.01). Neither diazoxide nor glibenclamide had an effect on control kidney function other than an increase in renal vascular resistance produced by glibenclamide. Pretreatment with 200 muM diazoxide reduced the postischemic increase in FENa (p < 0.05). Adding 10 muM glibenclamide inhibited the diazoxide effect on postischemic FENa (p < 0.01). Histology showed that kidneys pretreated with glibenclamide demonstrated an increase in injure in the thick ascending limb of outer medulla (p < 0.05). Glibenclamide significantly decreased post ischemic renal vascular resistance (p < 0.05). but had no significant effect on other renal function parameters. Our results suggest that sodium reabsorption is improved by K-ATP activation and blockade of K-ATP channels during IRI has an injury enhancing effect on renal epithelial function and histology. This may be mediated through K-ATP modulation in cell and or mitochondrial inner membrane